{"title":"COVID - 19疫苗:我们如何做得这么好?","authors":"E. Riley","doi":"10.1002/tre.802","DOIUrl":null,"url":null,"abstract":"Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.","PeriodicalId":425190,"journal":{"name":"Trends - Urology & Men's Health","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID‐19 vaccines: how did we do so well?\",\"authors\":\"E. Riley\",\"doi\":\"10.1002/tre.802\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.\",\"PeriodicalId\":425190,\"journal\":{\"name\":\"Trends - Urology & Men's Health\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends - Urology & Men's Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tre.802\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends - Urology & Men's Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tre.802","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.